May 30, 2025 -- The FDA has approved a new treatment for dry eye disease (DED) after studies showed it can help stimulate natural tear production as early as the first day of use. The new drug, known ...
The FDA granted priority review to veligrotug for the treatment of thyroid eye disease, according to a press release from Viridian Therapeutics.
The phase 3 trial showed reproxalap's statistical superiority over the vehicle in relieving ocular discomfort and was well tolerated. Despite meeting the primary endpoint, the FDA found insufficient ...
The company will stop two trials testing its blockbuster therapy Vyvgart in thyroid eye disease after treatment was judged to ...
New research has discovered certain weight-loss medications could be associated with an increased risk of serious eye conditions, and even vision loss. Two studies, published in JAMA, analyzed how ...
Outlook shares hit record low after FDA decision FDA cites lack of substantial evidence for drug's effectiveness Company plans to meet with FDA to gain clarity on requirements Aug 28 (Reuters) - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback